| mRNA |
TAE684 |
GDSC1000 |
pan-cancer |
AAC |
0.0077 |
0.9 |
| mRNA |
I-BET151 |
CTRPv2 |
pan-cancer |
AAC |
0.0046 |
0.9 |
| mRNA |
SR8278 |
CTRPv2 |
pan-cancer |
AAC |
-0.02 |
0.9 |
| mRNA |
BRD-K33514849 |
CTRPv2 |
pan-cancer |
AAC |
-0.019 |
0.9 |
| mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0053 |
0.9 |
| mRNA |
ABT-199 |
CTRPv2 |
pan-cancer |
AAC |
0.0063 |
0.9 |
| mRNA |
navitoclax:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0051 |
0.9 |
| mRNA |
AC55649 |
CTRPv2 |
pan-cancer |
AAC |
0.0054 |
0.9 |
| mRNA |
GDC-0941 |
gCSI |
pan-cancer |
AAC |
0.0085 |
0.9 |
| mRNA |
BRD-K41334119 |
CTRPv2 |
pan-cancer |
AAC |
-0.011 |
0.9 |